A Reality Check On Artificial Intelligence: Are Health Care Claims Overblown?
As happens when the tech industry gets involved, hype surrounds the claims that artificial intelligence will help patients and even replace some doctors.
FDA
341-360 of 483 results
-
-
Reports Of Patients鈥 Deaths Linked To Heart Devices Lurk Below Radar
Because of a little-known federal exemption program, death data about heart devices sits in inaccessible FDA files that can take up to two years for the public to see under open-records laws.
-
Promising Greater Safety, A Tiny Widget Creates Chaos For Tube Feeders
A standard connector for feeding tubes was supposed to improve patient safety by preventing accidental misconnections to equipment used for IVs or other purposes. But critics say the design instead could keep patients from real food and inadvertently creates a host of new risks, including for vulnerable premature infants.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
KHN鈥檚 鈥榃hat The Health?鈥: We Spend HOW MUCH On Health Care?
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation鈥檚 economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Markian Hawryluk about the latest KHN-NPR 鈥淏ill of the Month.鈥
-
Medical Device Failures Brought To Light Now Bolster Lawsuits And Research
Millions of injuries and malfunctions once funneled into a hidden Food and Drug Administration database are now available.
-
No Safety Switch: How Lax Oversight Of Electronic Health Records Puts Patients At Risk
Special interests and congressional inaction blocked efforts to track the safety of electronic medical records, leaving patients at risk.
By Fred Schulte and Erika Fry, Fortune -
A Regulatory Haze: Vape Marketers Are Online, Creating New Headaches For Feds
The subculture around vaping has been fueled by social media, and traditional regulations don鈥檛 easily address potential pitfalls.
By Shefali Luthra and Chaseedaw Giles -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Flavor Bans Multiply, But Menthol Continues to Divide
As states and communities ban the sale of flavored tobacco products linked to vaping, anti-smoking activists are piggybacking on the momentum to target menthol cigarettes. But some African Americans say menthol cigarette bans will lead to discrimination.
-
FDA Keeps Brand-Name Drugs On A Fast Path To Market 鈥 Despite Manufacturing Concerns
The agency approved Gilead鈥檚 鈥済ame changer鈥 hepatitis C cure, bypassing concerns raised by its own federal inspectors.
-
A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms
Companies are aggressively touting 3D mammograms, although there鈥檚 no evidence they save lives.
By Liz Szabo -
Vapers Accuse Officials Of Overreach As Investigation Into Deadly Lung Illness Lags
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.
-
Skin-Lightening Cream Put A Woman Into A Coma. It Could Happen Again.
A Sacramento woman is in a coma after using a face cream from Mexico. It is the nation鈥檚 first case of methylmercury poisoning from a cosmetic, and public health officials can do almost nothing to prevent other contaminated cosmetics from hitting the shelves.
-
At Raucous Hearing, No Unity On Vaping Issues
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
By Rachel Bluth -
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients鈥 Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication鈥檚 long production window.
-
Camouflaged Vaping Devices Are Hoodwinking Parents And Schools
The vaping hoodie. The vaping watch. The vaping phone case. Each ready to deliver a puff of nicotine (or marijuana) anywhere, anytime. The vaping market is crowded with sleek, camouflaged devices that have teachers and parents struggling to monitor illicit usage of a product that has surged in popularity among high schoolers.
-
Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
-
Purveyors Of Black-Market Pharmaceuticals Target Immigrants
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.